US Broker Ratings

Sonida Senior Living, Inc. (SNDA): Investor Outlook Amidst Robust Revenue Growth and Challenging Valuations

Sonida Senior Living, Inc. (SNDA), a key player in the healthcare sector specializing in medical care facilities, has caught the attention of investors with its impressive..

Kura Oncology, Inc. (KURA) Stock Analysis: Unpacking a 217.61% Potential Upside in the Biotech Space

Kura Oncology, Inc. (NASDAQ: KURA), a clinical-stage biopharmaceutical company based in San Diego, California, has been making waves in the biotechnology sector with its promising pipeline..

Septerna, Inc. (SEPN) Stock Analysis: Unveiling a Potential 18.88% Upside with Groundbreaking Biotech Innovations

Septerna, Inc. (NASDAQ: SEPN) is making waves in the biotechnology sector with its innovative approaches to treating complex diseases through G protein-coupled receptor (GPCR) oral small..

Definitive Healthcare Corp. (DH) Stock Analysis: A 30% Upside Potential Amidst Sector Challenges

Definitive Healthcare Corp. (NASDAQ: DH), a key player in the healthcare information services industry, presents a compelling investment opportunity with a notable 30.66% potential upside, according..

Cullinan Therapeutics (CGEM) Stock Analysis: Exploring a Potential 180% Upside in the Biotech Sector

Cullinan Therapeutics, Inc. (NASDAQ: CGEM), a promising player in the biotechnology industry, is capturing the attention of investors with its innovative approach to developing therapies for..

Geron Corporation (GERN) Stock Analysis: Exploring a Potential 172% Upside in Biotech

Geron Corporation (NASDAQ: GERN), a prominent player in the biotechnology sector, is capturing investor attention with its ambitious growth prospects. Specializing in oncology therapeutics, this commercial-stage..

AnaptysBio, Inc. (ANAB) Stock Analysis: Exploring a 34% Potential Upside in the Biotechnology Sector

AnaptysBio, Inc. (NASDAQ: ANAB), a clinical-stage biotechnology company, has been gaining traction among investors, particularly those interested in the healthcare sector’s dynamic and innovative landscape. With..

Arbutus Biopharma Corporation (ABUS) Stock Analysis: Exploring the 19% Upside Potential in the Biotech Sector

Arbutus Biopharma Corporation (NASDAQ: ABUS) is making waves in the biotechnology sector with its promising outlook in developing novel therapeutics for infectious diseases, particularly chronic Hepatitis..

Sana Biotechnology, Inc. (SANA) Stock Analysis: Exploring a Promising 110.6% Potential Upside

Sana Biotechnology, Inc. (NASDAQ: SANA) is garnering attention in the biotechnology sector with its innovative approach to developing engineered cells as medicines. As a U.S-based company,..

iRadimed Corporation (IRMD): Investor Outlook on Growth Potential in the Healthcare Sector

iRadimed Corporation (NASDAQ: IRMD) is carving a niche in the healthcare sector with its innovative medical devices, specifically designed for MRI compatibility. With a focus on..

Trevi Therapeutics, Inc. (TRVI) Stock Analysis: A 70% Upside Potential That Demands Investor Attention

Trevi Therapeutics, Inc. (NASDAQ: TRVI), a promising player in the biotechnology sector, is garnering increased attention from investors thanks to its substantial upside potential. With a..

Ginkgo Bioworks Holdings, Inc. (DNA) Stock Analysis: Navigating Potential Upside Despite Challenges

Ginkgo Bioworks Holdings, Inc. (NYSE: DNA) stands at a fascinating intersection of biotechnology and innovation, offering a potentially rewarding yet challenging investment landscape. As a leading..

Cross Country Healthcare, Inc. (CCRN) Stock Analysis: Exploring a 19.29% Potential Upside in the Healthcare Sector

Cross Country Healthcare, Inc. (NASDAQ: CCRN) is attracting attention in the healthcare sector, not just for its comprehensive staffing solutions but also for its intriguing market..

Taysha Gene Therapies, Inc. (TSHA) Stock Analysis: Exploring a 96% Potential Upside in the Promising Biotech Sector

As Taysha Gene Therapies, Inc. (NASDAQ: TSHA) continues to innovate within the biotechnology sector, individual investors are taking a closer look at its potential for substantial..

Neuropace, Inc. (NPCE) Stock Analysis: A Promising 24.68% Upside in the Healthcare Sector

Neuropace, Inc. (NPCE) stands out in the healthcare sector with its innovative approach to treating drug-resistant focal epilepsy. Operating within the medical devices industry, Neuropace has..

Altimmune, Inc. (ALT) Stock Analysis: A Biotech Play with a 391.69% Potential Upside

Investors eyeing the healthcare sector’s cutting-edge developments may find Altimmune, Inc. (NASDAQ: ALT) a compelling opportunity, particularly given its staggering potential upside of 391.69% based on..

Orthofix Medical Inc. (OFIX): Investor Outlook with a 50.40% Potential Upside

Orthofix Medical Inc. (NASDAQ: OFIX), a prominent player in the healthcare sector specializing in medical devices, presents a compelling investment opportunity. With a market capitalization of..

Semler Scientific, Inc. (SMLR) Investor Outlook: A Potential 329% Upside in the Medical Device Sector

Semler Scientific, Inc. (NASDAQ: SMLR) presents a compelling opportunity for investors intrigued by the healthcare sector, specifically within the burgeoning field of medical devices. Headquartered in..

Keros Therapeutics, Inc. (KROS) Stock Analysis: Unveiling a 14.81% Potential Upside in the Biotech Arena

For investors keen on the biotechnology sector, Keros Therapeutics, Inc. (NASDAQ: KROS) presents a compelling opportunity. With a market capitalization of $620.29 million, this clinical-stage biopharmaceutical..

Intellia Therapeutics (NTLA) Investor Outlook: Analyzing the 149% Upside Potential

For investors keeping a close watch on innovative biotechnology firms, Intellia Therapeutics, Inc. (NASDAQ: NTLA) presents a compelling case. Recent data highlights a significant potential upside..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds